Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 60 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-09-05 Bolzon Bradley J PhD Director Other disposition −8,110 16,224
2017-09-05 Bolzon Bradley J PhD Director Other disposition −814,599 1,629,204
2017-09-05 Bolzon Bradley J PhD Director Other disposition −23,899 47,801
2017-09-05 Bolzon Bradley J PhD Director Other disposition −61,993 123,994
2017-09-05 Bolzon Bradley J PhD Director Other disposition −26,491 52,987
2017-09-05 Bolzon Bradley J PhD Director Other acquisition +292,529 292,529
2017-09-05 Bolzon Bradley J PhD Director Other disposition −292,529 0
2017-09-05 Bolzon Bradley J PhD Director Other acquisition +17,283 17,283
2017-09-05 Bolzon Bradley J PhD Director Other disposition −17,283 0
2017-09-05 Bolzon Bradley J PhD Director Other acquisition +1,240 1,240
2017-09-05 Bolzon Bradley J PhD Director Other disposition −1,240 0
2017-09-05 Bolzon Bradley J PhD Director Other acquisition +55,447 55,447
2017-09-05 Novak Rodger Chief Executive Officer Option exercise +3,853 $1.81 $7K 1,151,860
2017-09-05 Novak Rodger Chief Executive Officer Sale −3,853 $20.33 $78K 1,148,007
2017-09-05 Novak Rodger Chief Executive Officer Option exercise · Stock Options (Right to Buy) −3,853 40,826
2017-08-31 Novak Rodger Chief Executive Officer Sale −14,617 $20.87 $305K 1,148,007
2017-08-30 Novak Rodger Chief Executive Officer Option exercise +5,722 $1.81 $10K 1,220,727
2017-08-30 Novak Rodger Chief Executive Officer Sale −58,103 $20.31 $1.2M 1,162,624
2017-08-30 Novak Rodger Chief Executive Officer Option exercise · Stock Options (Right to Buy) −5,722 44,679
2017-08-30 Kulkarni Samarth Chief Business Officer Sale −4,000 $20.00 $80K 106,893

Page 60 of 62 · 1,221 trades